Search - tctmd.com

Displaying 21 - 40 of 216

Sort: Relevancy | Date

News Daily News

Switch Anticoagulants for A-fib Patients Needing a Stent? RE-DUAL PCI Insights

Shelley Wood

December 02, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2019

Shelley Wood

November 29, 2019

News Features

Subtherapeutic Heparin: As Stories Multiply, Concerns Mount

Yael L. Maxwell

November 27, 2019

News Daily News

Elderly Women Worse Off Than Men Before and After Acute MI

Yael L. Maxwell

October 22, 2019

News Conference News SCAI 2019

Cancer and CV Disease Care: What’s Known? What Lies Ahead for Cardio-Oncology?

Yael L. Maxwell

May 30, 2019

News Daily News

Continuing Anticoagulation During TAVR in A-fib Patients May Be Safe, Study Suggests

Todd Neale

January 09, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2018

Shelley Wood

November 30, 2018

News Conference News ESC 2018

MATRIX: 1-Year Results Confirm Superiority of Transradial PCI

Michael O'Riordan

August 25, 2018

News Daily News

Bleeding and Ischemic Events Fluctuate Out to 1 Year Post-STEMI: HORIZONS-AMI

Yael L. Maxwell

October 03, 2017

News Daily News

New Performance and Quality Metrics for STEMI and NSTEMI Care

Michael O'Riordan

September 21, 2017

News Conference News ESC 2017

ESC Updates Guidelines for Treating STEMI Patients

Michael O'Riordan

August 27, 2017

News Conference News ESC 2017

Latest Bivalirudin, Heparin Face-off in MI Cements Winner in Routine Practice: VALIDATE-SWEDEHEART

Shelley Wood

August 27, 2017

Presentation ESC 2017

Bivalirudin vs Heparin Monotherapy in Myocardial Infarction:The VALIDATE-SWEDEHEART Trial

Presenter: David Erlinge

August 27, 2017

Presentation

Primary PCI Outcomes in STEMI Patients Treated via Radial Access With Bivalirudin or Heparin

May 23, 2017

News Daily News

Large US Study Suggests Little Difference Between Bivalirudin and Heparin for Transradial Primary PCI

Todd Neale

May 22, 2017

News Daily News

Faster Primary PCIs Linked to Higher Stent Thrombosis Risk With Bivalirudin

Todd Neale

March 07, 2017

News Daily News

With No RCTs, Propensity-Score Matched Analysis Informs Choice Between Cangrelor and GPIs in the Cath Lab

Yael L. Maxwell

December 06, 2016

News Daily News

Sin ECA, el Análisis de Emparejamiento por Puntuación de la Propensión permite tomar una Decisión Informada entre Cangrelor y GPI en el Laboratorio de Cateterización

Yael L. Maxwell

December 06, 2016

News Daily News

Registry Data Show Rise and Fall of Bivalirudin vs Heparin for Primary PCI

Yael L. Maxwell

November 11, 2016

News Daily News

Datos de Registro Revelan el Ascenso y Caída de la Bivalirudina frente a la Heparina en la Realización de PCI Primarias

Yael L. Maxwell

November 11, 2016

Advertisement

Switch Anticoagulants for A-fib Patients Needing a Stent? RE-DUAL PCI Insights

TCTMD’s Top 10 Most Popular Stories for November 2019

Subtherapeutic Heparin: As Stories Multiply, Concerns Mount

Elderly Women Worse Off Than Men Before and After Acute MI

Cancer and CV Disease Care: What’s Known? What Lies Ahead for Cardio-Oncology?

Continuing Anticoagulation During TAVR in A-fib Patients May Be Safe, Study Suggests

TCTMD’s Top 10 Most Popular Stories for November 2018

MATRIX: 1-Year Results Confirm Superiority of Transradial PCI

Bleeding and Ischemic Events Fluctuate Out to 1 Year Post-STEMI: HORIZONS-AMI

New Performance and Quality Metrics for STEMI and NSTEMI Care

ESC Updates Guidelines for Treating STEMI Patients

Latest Bivalirudin, Heparin Face-off in MI Cements Winner in Routine Practice: VALIDATE-SWEDEHEART

Bivalirudin vs Heparin Monotherapy in Myocardial Infarction:The VALIDATE-SWEDEHEART Trial

Primary PCI Outcomes in STEMI Patients Treated via Radial Access With Bivalirudin or Heparin

Large US Study Suggests Little Difference Between Bivalirudin and Heparin for Transradial Primary PCI

Faster Primary PCIs Linked to Higher Stent Thrombosis Risk With Bivalirudin

With No RCTs, Propensity-Score Matched Analysis Informs Choice Between Cangrelor and GPIs in the Cath Lab

Sin ECA, el Análisis de Emparejamiento por Puntuación de la Propensión permite tomar una Decisión Informada entre Cangrelor y GPI en el Laboratorio de Cateterización

Registry Data Show Rise and Fall of Bivalirudin vs Heparin for Primary PCI

Datos de Registro Revelan el Ascenso y Caída de la Bivalirudina frente a la Heparina en la Realización de PCI Primarias

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content